US Patent 10945992 Dosage forms of rofecoxib and related methods
Patent 10945992 was granted and assigned to Tremeau Pharmaceuticals, Inc. on March, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10945992 Dosage forms of rofecoxib and related methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
